Kenvue Inc.
KVUE
Rang in aandelen
#662
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Aandeelprijs
$19.29
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$37.05B
Verandering (1 dag)
2.23%
Verandering (1 jaar)
29.20%
Land
US
Handel Kenvue Inc. (KVUE)
Categorie
Consumer Defensive
Winst voor Kenvue Inc. (KVUE)
Winst in Jun 2026 TTM: $2.22B
Volgens de meest recente financiële verslagen van Kenvue Inc. bedraagt de huidige winst van het bedrijf $2.22B. In 2023 behaalde het bedrijf een winst van $2.19B, een daling ten opzichte van de winst van 2022, die $2.64B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Kenvue Inc. van 2019 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $2.22B | 57.10% |
| 2024 | $1.42B | -35.39% |
| 2023 | $2.19B | -16.95% |
| 2022 | $2.64B | -9.85% |
| 2021 | $2.93B | -387.89% |
| 2020 | $-1.02B | -147.92% |
| 2019 | $2.12B | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $20.38B | 816.64% |
US
|
|
| $9.83B | 342.03% |
FR
|
|
| $2.94B | 32.30% |
US
|
|
| $1.55B | -30.27% |
IN
|
|
| $517.00M | -76.74% |
US
|
